Sanford Guide Introduces New Hepatitis Guide
Sanford Guide to Hepatitis Diagnosis and Treatment available in mobile app
CHICAGO, Sept. 17, 2011 /PRNewswire/ -- The Sanford Guide, recognized as the essential reference for infectious disease treatment, announced the release of the Sanford Guide to Hepatitis Diagnosis and Treatment today at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). This is the first mobile app of its kind for Hepatitis treatment, making it easy for healthcare professionals anywhere in the world to find the latest treatment guidelines instantly.
Hepatitis was recently identified by the World Health Organization (WHO) as a matter of global concern, affecting nearly one of every three people in the world. WHO held a World Hepatitis Day in August to highlight the worldwide scope of this increasingly prevalent disease. The new Sanford Guide, whose editors are among the world's foremost infectious disease experts, assists health care professionals who specialize in the care and management of patients with Hepatitis or whose practice in this area is growing, by providing convenient access to critical information at the point of care.
"A revolution is occurring in the treatment of Hepatitis C virus infections, similar in magnitude to the rapid change in HIV therapy in the mid-1990s," said Jeb Sanford, managing editor. "A major difference between HIV therapy and Hepatitis C therapy is that patients can be cured of Hepatitis C infections. New drugs approved in 2011 are transforming therapeutic approaches to Hepatitis C treatment and many more new drugs are in development."
The Sanford Guide to Hepatitis Diagnosis and Treatment covers:
- Hepatitis C diagnosis, epidemiology, natural history, clinical presentation, treatment setting and treatment
- Hepatitis A treatment of acute infections
- Hepatitis B treatment of chronic infections, management of exposure, prophylaxis in transplant patients
- Hepatitis immunization recommendations
- Comprehensive drug information for anti-Hepatitis agents, including usage, dosage, dose adjustments, adverse effects, pharmacology and major interactions with other drugs
The mobile app for this Guide is available on Apple's App Store and the Android Market. Advantages to using a mobile application rather than a printed booklet include easy navigation and search tools and links to related material and source references. Regular updates will reflect new drugs, shifting response patterns, and the changing availability and efficacy of anti-infective therapies. The expanded Hepatitis coverage is also included in the Sanford Guide Web Edition and in the upcoming 20th edition of The Sanford Guide to HIV/AIDS Therapy.
About Sanford Guide
Sanford Guide provides the leading authoritative reference guides for the treatment of infectious diseases to health care providers at the "point of care." The Sanford Guide delivers convenient, comprehensive recommendations for treatment and prevention of bacterial, fungal, viral, retroviral, parasitic and mycobacterial infections. It provides recommendations for surgical prophylaxis, and comprehensive anti-infective drug information, all supported by expert commentary and evidence-based references. Antimicrobial Therapy, Inc., publisher of the Sanford Guides, has been owned and operated by the Sanford family since 1969. More information is available at www.sanfordguide.com.
CONTACT:
Hailee Lampert
Peritus Public Relations
(502) 510-2349
[email protected]
SOURCE Antimicrobial Therapy, Inc.
Share this article